Laurion Capital Management LP Cellectis S.A. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$15.58 - $28.41 $2.1 Million - $3.83 Million	-134,700 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$25.99 - $30.6 $1.7 Million - $2 Million	-65,300 Reduced 32.65%	134,700 $3.8 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $5.56 Million - $7.71 Million	200,000 New	200,000 $5.66 Million

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.